Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tanja D de Gruijl"'
Autor:
Martino Ambrosini, Sanne Duinkerken, Juan J. Garcia-Vallejo, Tanja D. de Gruijl, Lisa Rutte, Hakan Kalay, Sophie K. Horrevorts, Yvette van Kooyk
Publikováno v:
Duinkerken, S, Horrevorts, S K, Kalay, H, Ambrosini, M, Rutte, L, de Gruijl, T D, Garcia-Vallejo, J J & van Kooyk, Y 2019, ' Glyco-dendrimers as intradermal anti-tumor vaccine targeting multiple skin DC subsets ', Theranostics, vol. 9, no. 20, pp. 5797-5809 . https://doi.org/10.7150/thno.35059
Theranostics, 9, 5797-5809
Theranostics
Theranostics, 9(20), 5797-5809. Ivyspring International Publisher
Theranostics, 9, 20, pp. 5797-5809
Theranostics, 9, 5797-5809
Theranostics
Theranostics, 9(20), 5797-5809. Ivyspring International Publisher
Theranostics, 9, 20, pp. 5797-5809
Contains fulltext : 215802.pdf (Publisher’s version ) (Open Access) The human skin is an attractive anti-tumor vaccination site due to the vast network of dendritic cell (DC) subsets that carry antigens to the draining lymph nodes and stimulate tum
Autor:
Tom O'Toole, Yvette van Kooyk, Katarzyna Olesek, Joke M. M. den Haan, Floris J. Bikker, Eline S. Zwart, Geert Kazemier, Alsya J. Affandi, Helen J Pijffers, Joanna Grabowska, Ernesto Rodríguez, Tanja D. de Gruijl, Martino Ambrosini, Johannes Stöckl, Patrick P G Mulder, Kamran Nazmi, Gert Storm, Hakan Kalay, Miguel Lopez Venegas, Arnaud Barbaria, Alfons J.M. van den Eertwegh
Publikováno v:
Affandi, A J, Grabowska, J, Olesek, K, Venegas, M L, Barbaria, A, Rodríguez, E, Mulder, P P G, Pijffers, H J, Ambrosini, M, Kalay, H, O’Toole, T, Zwart, E S, Kazemier, G, Nazmi, K, Bikker, F J, Stöckl, J, van den Eertwegh, A J M, de Gruijl, T D, Storm, G, van Kooyk, Y & den Haan, J M M 2020, ' Selective tumor antigen vaccine delivery to human CD169 + antigen-presenting cells using ganglioside-liposomes ', Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 44, pp. 27528-27539 . https://doi.org/10.1073/pnas.2006186117
Proceedings of the National Academy of Sciences of the United States of America
Affandi, A J, Grabowska, J, Olesek, K, Lopez Venegas, M, Barbaria, A, Rodríguez, E, Mulder, P P G, Pijffers, H J, Ambrosini, M, Kalay, H, O'Toole, T, Zwart, E S, Kazemier, G, Nazmi, K, Bikker, F J, Stöckl, J, van den Eertwegh, A J M, de Gruijl, T D, Storm, G, van Kooyk, Y & den Haan, J M M 2020, ' Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes ', Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 44, pp. 27528-27539 . https://doi.org/10.1073/pnas.2006186117
Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27528-27539. National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27528-27539. National Acad Sciences
Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27528. National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America
Affandi, A J, Grabowska, J, Olesek, K, Lopez Venegas, M, Barbaria, A, Rodríguez, E, Mulder, P P G, Pijffers, H J, Ambrosini, M, Kalay, H, O'Toole, T, Zwart, E S, Kazemier, G, Nazmi, K, Bikker, F J, Stöckl, J, van den Eertwegh, A J M, de Gruijl, T D, Storm, G, van Kooyk, Y & den Haan, J M M 2020, ' Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes ', Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 44, pp. 27528-27539 . https://doi.org/10.1073/pnas.2006186117
Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27528-27539. National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27528-27539. National Acad Sciences
Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27528. National Academy of Sciences
Significance Current immunotherapies only benefit a minority of all cancer patients, so it is necessary to develop other strategies to boost patients’ antitumor CD8+ T cell responses. Here, we formulated a liposomal vaccine carrier that selectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b5b0bd2f3d5b21a1135dc801af5210a
https://hdl.handle.net/1871.1/cd09ac07-dd23-4fd5-bd76-87f3083ea0b311245.1/3914c7d1-8c17-47bd-aaff-f6dbcfb36ea3
https://hdl.handle.net/1871.1/cd09ac07-dd23-4fd5-bd76-87f3083ea0b311245.1/3914c7d1-8c17-47bd-aaff-f6dbcfb36ea3
Autor:
Dorian A. Stolk, Aram de Haas, Jana Vree, Sanne Duinkerken, Joyce Lübbers, Rieneke van de Ven, Martino Ambrosini, Hakan Kalay, Sven Bruijns, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Stolk, D A, de Haas, A, Vree, J, Duinkerken, S, Lübbers, J, van de Ven, R, Ambrosini, M, Kalay, H, Bruijns, S, van der Vliet, H J, de Gruijl, T D & van Kooyk, Y 2020, ' Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T-and iNKT Cell Responses ', Frontiers in Immunology, vol. 11, 990 . https://doi.org/10.3389/fimmu.2020.00990
Frontiers in Immunology
Frontiers in Immunology, 11:990
Stolk, D A, de Haas, A, Vree, J, Duinkerken, S, Lübbers, J, van de Ven, R, Ambrosini, M, Kalay, H, Bruijns, S, van der Vliet, H J, de Gruijl, T D & van Kooyk, Y 2020, ' Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T-and iNKT Cell Responses ', Frontiers in Immunology, vol. 11, 990 . https://doi.org/10.3389/fimmu.2020.00990
Frontiers in Immunology
Frontiers in Immunology, 11:990
In this study we developed a liposome-based vaccine containing palmitoylated synthetic long peptides (SLP) and alpha galactosylceramide (αGC) to specifically target dendritic cells (DC) for activation of both innate (invariant natural killer T-cells
Autor:
Dieke van Dinther, Tanja D. de Gruijl, Yvette van Kooyk, Joke M. M. den Haan, Rieneke van de Ven, Dorian A. Stolk
Publikováno v:
van Dinther, D, Stolk, D A, van de Ven, R, van Kooyk, Y, de Gruij, T D & den Haan, J M M 2017, ' Targeting C-type lectin receptors : A high-carbohydrate diet for dendritic cells to improve cancer vaccines ', Journal of Leukocyte Biology, vol. 102, no. 4, pp. 1017-1034 . https://doi.org/10.1189/jlb.5MR0217-059RR
Journal of Leukocyte Biology
Journal of Leukocyte Biology
Review of in vivo targeting of tumor antigens to lectin receptors on antigen-presenting cells using antibodies or ligands may improve the antitumor efficacy of vaccines.
There is a growing understanding of why certain patients do or do not respo
There is a growing understanding of why certain patients do or do not respo
Autor:
Marvin M. van Luijn, Jurjen M. Ruben, Hetty J. Bontkes, Tanja D. de Gruijl, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Theresia M. Westers, Willemijn van den Ancker
Publikováno v:
Cancer Immunology and Immunotherapy, 60(1), 37-47. Springer Science and Business Media Deutschland GmbH
Cancer Immunology, Immunotherapy
van den Ancker, W, van Luijn, M M, Ruben, J M, Westers, T M, Bontkes, H J, Ossenkoppele, G J, de Gruijl, T D & van de Loosdrecht, A A 2011, ' Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation ', Cancer Immunology and Immunotherapy, vol. 60, no. 1, pp. 37-47 . https://doi.org/10.1007/s00262-010-0917-y
Cancer Immunology, Immunotherapy
van den Ancker, W, van Luijn, M M, Ruben, J M, Westers, T M, Bontkes, H J, Ossenkoppele, G J, de Gruijl, T D & van de Loosdrecht, A A 2011, ' Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation ', Cancer Immunology and Immunotherapy, vol. 60, no. 1, pp. 37-47 . https://doi.org/10.1007/s00262-010-0917-y
Therapeutic vaccination with dendritic cells (DC) is an emerging investigational therapy for eradication of minimal residual disease in acute myeloid leukemia. Various strategies are being explored in manufacturing DC vaccines ex vivo, e.g., monocyte
Autor:
Erik Hooijberg, Chris J.L.M. Meijer, Duco Kramer, Rik J. Scheper, Janneke J. Ruizendaal, Hetty J. Bontkes, Tanja D. de Gruijl, Saskia J. A. M. Santegoets
Publikováno v:
Journal of Immunotherapy, 29(2), 188-200. Lippincott Williams and Wilkins
Bontkes, H J, Ruizendaal, J J, Kramer, D, Santegoets, S J A M, Scheper, R J, De Gruijl, T D, Meijer, C J L M & Hooijberg, E 2006, ' Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells ', Journal of Immunotherapy, vol. 29, no. 2, pp. 188-200 . https://doi.org/10.1097/01.cji.0000197095.00359.67
Bontkes, H J, Ruizendaal, J J, Kramer, D, Santegoets, S J A M, Scheper, R J, De Gruijl, T D, Meijer, C J L M & Hooijberg, E 2006, ' Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells ', Journal of Immunotherapy, vol. 29, no. 2, pp. 188-200 . https://doi.org/10.1097/01.cji.0000197095.00359.67
The CD34+ human acute myeloid leukemia-derived cell line MUTZ-3 is dependent on hematopoietic growth factors for its proliferation and is able to differentiate into dendritic cells (DCs) in response to the combination of granulocyte-macrophage colony